A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
<p class="p1"><span class="s1">Features and possibility of application of the calcium channel blocker lercanidipine in cardiology practice are discussed. The use of lercanidipine in patients with hypertension is supported by extensive evidences. The use of lercanidipi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | http://www.rpcardio.ru/jour/article/view/329 |
| _version_ | 1827841497795395584 |
|---|---|
| author | E. I. Emelina G. E. Gendlin |
| author_facet | E. I. Emelina G. E. Gendlin |
| author_sort | E. I. Emelina |
| collection | DOAJ |
| description | <p class="p1"><span class="s1">Features and possibility of application of the calcium channel blocker lercanidipine in cardiology practice are discussed. The use of lercanidipine in patients with hypertension is supported by extensive evidences. The use of lercanidipine in certain categories of patients, including patients receiving combination therapy is also considered. The safety of lercanidipine in cardiac patients is discussed separately.<br /> </span></p> |
| first_indexed | 2024-03-12T07:52:16Z |
| format | Article |
| id | doaj.art-df37b2baf8c94223b83e8d69b87ee531 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-03-12T07:52:16Z |
| publishDate | 2015-11-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-df37b2baf8c94223b83e8d69b87ee5312023-09-02T20:34:36ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-11-0111553554210.1234/1819-6446-2015-5-535-542329A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generationE. I. Emelina0G. E. Gendlin1Российский национальный исследовательский медицинский университет им. Н.И. Пирогова 117997, Москва, ул. Островитянова, 1Российский национальный исследовательский медицинский университет им. Н.И. Пирогова 117997, Москва, ул. Островитянова, 1<p class="p1"><span class="s1">Features and possibility of application of the calcium channel blocker lercanidipine in cardiology practice are discussed. The use of lercanidipine in patients with hypertension is supported by extensive evidences. The use of lercanidipine in certain categories of patients, including patients receiving combination therapy is also considered. The safety of lercanidipine in cardiac patients is discussed separately.<br /> </span></p>http://www.rpcardio.ru/jour/article/view/329лерканидипинартериальная гипертензиябезопасность лечения |
| spellingShingle | E. I. Emelina G. E. Gendlin A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation Рациональная фармакотерапия в кардиологии лерканидипин артериальная гипертензия безопасность лечения |
| title | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation |
| title_full | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation |
| title_fullStr | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation |
| title_full_unstemmed | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation |
| title_short | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation |
| title_sort | modern choice for patients with hypertension the possibility of new calcium antagonist of iii generation |
| topic | лерканидипин артериальная гипертензия безопасность лечения |
| url | http://www.rpcardio.ru/jour/article/view/329 |
| work_keys_str_mv | AT eiemelina amodernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration AT gegendlin amodernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration AT eiemelina modernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration AT gegendlin modernchoiceforpatientswithhypertensionthepossibilityofnewcalciumantagonistofiiigeneration |